260 related articles for article (PubMed ID: 11088082)
21. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
22. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
[TBL] [Abstract][Full Text] [Related]
25. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
Kanwal F; Kramer J; Asch SM; Chayanupatkul M; Cao Y; El-Serag HB
Gastroenterology; 2017 Oct; 153(4):996-1005.e1. PubMed ID: 28642197
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
27. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
28. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.
McGinnis KA; Fultz SL; Skanderson M; Conigliaro J; Bryant K; Justice AC
J Clin Oncol; 2006 Nov; 24(31):5005-9. PubMed ID: 17075119
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.
Ayoola EA; Gadour MO
J Gastroenterol Hepatol; 2004 Jun; 19(6):665-9. PubMed ID: 15151622
[TBL] [Abstract][Full Text] [Related]
31. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
[TBL] [Abstract][Full Text] [Related]
32. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
[TBL] [Abstract][Full Text] [Related]
33. Viral pathogenesis of hepatocellular carcinoma in the United States.
Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER
Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
[TBL] [Abstract][Full Text] [Related]
34. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
Kohli A
Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
[No Abstract] [Full Text] [Related]
35. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, risk factors, and natural history of hepatocellular carcinoma.
Montalto G; Cervello M; Giannitrapani L; Dantona F; Terranova A; Castagnetta LA
Ann N Y Acad Sci; 2002 Jun; 963():13-20. PubMed ID: 12095924
[TBL] [Abstract][Full Text] [Related]
37. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
38. [Etiology of hepatocellular carcinomas in Madagascar: results of a study in Antananarivo from October 1995 to October 1996].
Zeller HG; Rakotonirina J; Morel B; Pécarrère JL; Lapprand M
Arch Inst Pasteur Madagascar; 1996; 63(1-2):62-6. PubMed ID: 12463021
[TBL] [Abstract][Full Text] [Related]
39. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
Hwang JC; Weng SF; Weng RH
Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma and hepatitis C in Mexico.
Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM
Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
